Recently, the U.S. Food and Drug Administration reviewed and authorized for marketing the Banyan Brain Trauma Indicators which are ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP), to evaluate mTBI in adults. Here, GFAP is linked to brain injury.